Bernstein: It's Time For Gilead To Pull The Trigger On This Acquisition By: Benzinga via Benzinga April 21, 2015 at 09:23 AM EDT Bernstein analyst Geoffrey Porges said it's time for Gilead Sciences, Inc. (NASDAQ: GILD) to continue the biotech M&A with a ... Read More >> Related Stocks: Gilead Sciences Vertex Pharmaceuticals